320 results on '"Preuss, Klaus-Dieter"'
Search Results
2. Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
3. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
4. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
5. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
6. Characterization of rare germline variants in familial multiple myeloma
7. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
8. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
9. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
10. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
11. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
12. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
13. B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
14. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells
15. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor
16. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
17. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
18. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenström macroglobulinemia
19. Autoantibodies against SUMO1-DHX35 in long-COVID
20. Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases
21. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
22. Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children
23. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case–control study
24. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits
25. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
26. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
27. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM
28. Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens
29. Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas
30. Role of specific B-cell receptor antigens in lymphomagenesis
31. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
32. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
33. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
34. Analysis of the antibody repertoire of lymphoma patients
35. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma
36. Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria
37. The B-Cell Receptor Antigen ARS2 Can be Integrated into a BAR-Body Format to Treat Diffuse Large B-Cell Lymphomas in Xenograft Mouse Models
38. Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies
39. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells
40. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
41. Human tumor antigens recognized by antibodies (SEREX)
42. Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS
43. Mitofilin and titin as target antigens in melanoma-associated retinopathy
44. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer
45. B-cell epitopes from the cancer testis antigen NY-ESO-1
46. Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom's macroglobulinaemia in Sweden
47. A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses
48. Analysis of the B-cell repertoire against antigens expressed by human neoplasms
49. Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom’s macroglobulinaemia in Sweden
50. Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.